Questions to Ask Before Buying AI for Health and Wellness Operations

Summary

Health and wellness AI can schedule appointments, summarize conversations, answer benefit questions, coach users, and route clinical messages—but a polished demonstration reveals little about operational safety. Before committing, leaders should establish what the system is allowed to do, which evidence supports its claims, where protected health information travels, and who intervenes when automation fails. The decisive question is not whether an agent sounds intelligent; it is whether the organization can govern its behavior across real patients, employees, systems, and edge cases. A defensible purchase therefore begins with workflow diagnosis and risk classification, not a vendor shortlist.

Explain like I'm 5

{"text":"Imagine hiring an extremely fast new assistant who can speak confidently but may occasionally misunderstand a person or invent an answer. Before giving that assistant access to appointment books, health records, payment systems, or vulnerable callers, you would decide exactly what it may do, check its work, supervise it, and create an emergency handoff. An AI agent needs the same controls—plus technical testing. Ask what information it sees, where that information goes, how long it is retained, whether humans review it, and what happens when it is uncertain. Buy the measurable workflow improvement, not the illusion that the software understands health like a licensed professional."}

Deep dive

{"blocks":[{"h2":"Begin with the consequential action, not the chatbot","text":"Write the proposed workflow as a sequence of decisions: authenticate the person, collect information, retrieve records, generate an answer, update a system, and escalate. Then label each step as administrative, supportive, or potentially clinical. An appointment reminder is not equivalent to symptom triage; drafting a note is not equivalent to filing it without review. Ask: What can the agent say, write, approve, deny, book, cancel, or disclose? What action is irreversible? Who owns the outcome? This exercise exposes whether the buyer is automating work or transferring judgment. Keep high-consequence decisions—diagnosis, treatment selection, crisis disposition, benefit denial, or medication changes—under appropriately qualified human authority unless a clearly authorized and validated system supports the use. Voice agents also require reliable identity checks and explicit disclosure policies. A fluent voice must not be mistaken for consent, comprehension, or clinical competence."},{"h2":"Interrogate evidence and product classification","text":"Demand evidence for the vendor’s precise claim. A retrospective benchmark, a vendor-authored case study, and a prospective trial answer different questions. Request error definitions, sample size, confidence intervals, subgroup performance, comparator, exclusion criteria, and publication status. If a product claims to improve outcomes, ask whether it measured outcomes or merely engagement. If it claims to reduce calls, check abandonment, repeat contacts, complaint rates, and downstream staff work. Intended use matters. Software marketed for general wellness or administration may sit outside medical-device oversight, while software intended to diagnose, treat, or provide certain patient-specific clinical recommendations may trigger FDA analysis. Obtain the vendor’s written regulatory rationale, current clearance details where applicable, and a process for reviewing feature changes. Do not let a contractual disclaimer contradict sales demonstrations or real deployment behavior."},{"h2":"Follow every byte and every subcontractor","text":"Create a data-flow diagram covering capture, transcription, inference, storage, analytics, support access, backups, deletion, and model improvement. Identify controllers, covered entities, business associates, subprocessors, hosting regions, and cross-border transfers. Ask whether prompts, recordings, transcripts, embeddings, metadata, and human-review queues contain protected health information. Confirm encryption, key management, role-based access, audit logs, retention controls, tenant isolation, incident notification, and deletion verification. HIPAA applies according to roles and data flows, not marketing language. A business associate agreement is necessary in many covered workflows but does not itself make the deployment safe. Consumer wellness data may instead—or additionally—fall under the FTC Act, the FTC Health Breach Notification Rule, state health-data laws, biometric rules, or general privacy statutes. Prohibit secondary training unless deliberately approved, technically bounded, and contractually documented."},{"h2":"Test the operating system around the model","text":"Model quality is only one component. Test accented speech, noisy rooms, interruptions, negation, code-switching, low health literacy, unavailable integrations, stale records, duplicate identities, adversarial prompts, and callers expressing self-harm or abuse. Measure task completion, unsupported statements, authentication failures, unsafe omissions, transfer success, latency, corrections, and equity across relevant groups. For generative outputs, establish review thresholds and provenance rather than relying on one aggregate accuracy score. Design the human handoff before launch. Specify triggers, queue destinations, context transferred, response-time targets, and what the user experiences after hours. Give staff a way to correct records and report recurrent failure modes. Maintain downtime procedures and a kill switch that does not disable essential access. The safest pilot has a narrow population, shadow or assisted mode, daily incident review, and predetermined pause criteria."},{"h2":"Price the whole change—and the exit","text":"Build the business case against a measured baseline: handle time, no-shows, documentation backlog, conversion, first-contact resolution, or staff overtime. Include implementation, integration, security review, telephony, model usage, human supervision, retraining, quality assurance, appeals, and vendor management. Avoid counting displaced minutes as savings unless capacity is actually removed or redeployed to valuable work. Before signing, secure service levels, audit rights, subprocessor notice, breach obligations, insurance expectations, data-export formats, deletion attestations, model-change notification, and assistance at termination. Clarify ownership of prompts, workflow configurations, recordings, generated content, and evaluation data. A credible vendor should support a reversible rollout. The strongest commitment is often a stage gate: discovery, controlled pilot, independent review, then expansion only if safety, adoption, and unit economics meet written thresholds."}]}

FAQs

Predictions

• Health organizations will likely procure bounded workflow agents more readily than general-purpose autonomous systems because approval, testing, and accountability are easier to define.
• Agent observability—action logs, source tracing, replay, policy checks, and automated evaluation—may become a standard enterprise buying requirement.
• Regulators and customers are likely to scrutinize intended use and demonstrated behavior more than labels such as ‘wellness assistant’ or ‘copilot.’
• Voice automation may expand fastest in scheduling, outreach, intake, and routine support, while clinical escalation remains deliberately human-led.
• Contracts may increasingly include model-change notices, evaluation access, data-lineage commitments, and measurable transition assistance.

Opportunities

• Automate low-risk administrative work such as scheduling, reminders, eligibility routing, and multilingual FAQs while preserving clear escalation.
• Use ambient or generative tools to draft documentation for accountable human review, reducing clerical burden without silently changing the record.
• Create a shared AI control plane for identity, permissions, evaluation, logging, and incident response across multiple vendors.
• Mine de-identified, properly governed workflow signals to identify call drivers, access bottlenecks, no-show patterns, and avoidable rework.
• Convert pilots into reusable evaluation assets: test suites, red-team scenarios, approved knowledge sources, and procurement clauses.

For professionals

{"text":"For an investment committee, the relevant unit of analysis is the sociotechnical control system, not the foundation model. Map each agent capability to a data classification, decision right, accountable executive, regulatory rationale, validation artifact, control owner, and residual-risk acceptance. Separate deterministic orchestration from probabilistic generation: authentication, authorization, eligibility logic, transaction limits, and crisis routing should rely on enforceable controls wherever possible, while generated language should be grounded, constrained, monitored, and reviewable. Track production performance by workflow version, model version, knowledge-base version, channel, and cohort; otherwise drift and regression become invisible. Commercial diligence should connect risk to economics. Calculate contribution after exception labor, audit sampling, telephony, inference, integration support, incident reserves, and adoption loss—not just per-minute automation. Use contract stage gates tied to agreed acceptance tests, including adversarial cases and failover. Require change control for models, subprocessors, data residency, safety policies, and material functionality; preserve audit logs and export rights in a usable schema. The board-level question is whether the organization can demonstrate that the agent remained within authority, protected sensitive information, produced measurable value, and failed safely. If evidence for any of those claims cannot be reconstructed after an incident, governance is incomplete."}

Sources & references

• NIST AI Risk Management Framework (AI RMF 1.0)
• WHO: Ethics and Governance of Artificial Intelligence for Health
• HHS: HIPAA for Professionals
• FDA: Artificial Intelligence-Enabled Medical Devices
• FTC: Health Breach Notification Rule
• European Commission: Regulatory Framework for AI
• HHS OCR: Guidance on HIPAA and Cloud Computing